Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EM0477 / 1||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Cardiac arrest
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Arteritis; Hypertension; Non-insulin-dependent diabetes mellitus
Diagnostic Lab Data:
CDC 'Split Type': FRPFIZER INC2021073665
Write-up: Cardiac arrest; This is a spontaneous report from a contactable other Healthcare Professional (HCP) from the Medicines Agency (MA) Regulatory Authority -WEB FR-AFSSAPS-CN20210070. An 89-year-old female patient living in a nursing house received the first dose of BNT162B2 (COMIRNATY, Lot # EM0477), intramuscular, on 18Jan2021 at single dose for COVID-19 immunisation. Medical history included arteritis, hypertension, non-insulin-dependent type 2 diabetes. The patient had not presented covid-19 (but not tested). Seven hours after administration of the vaccine, the patient suffered cardiac arrest. Death occurs 58 minutes later despite attempts at resuscitation on 18Jan2021. According to the declarer this effect was completely unexpected. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166